Trademark: 88023076
Status Date
Monday, September 6, 2021
Filing Date
Monday, July 2, 2018
Published for Opposition
Tuesday, December 11, 2018
Abandoned Date
Monday, September 6, 2021
5 Pharmaceutical preparations for the treatment of Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis
The wording "RIXZURE" has no meaning in a foreign language.
Sep 7, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 6, 2021
Abandonment - No Use Statement Filed
Jan 19, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 17, 2021
Extension 4 Granted
Jan 17, 2021
Extension 4 Filed
Jan 17, 2021
Teas Extension Received
Jul 28, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 24, 2020
Extension 3 Granted
Jul 24, 2020
Extension 3 Filed
Jul 24, 2020
Teas Extension Received
Jan 14, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 10, 2020
Extension 2 Granted
Jan 10, 2020
Extension 2 Filed
Jan 10, 2020
Teas Extension Received
Aug 1, 2019
Notice Of Approval Of Extension Request E-Mailed
Jul 30, 2019
Extension 1 Granted
Jul 30, 2019
Extension 1 Filed
Jul 30, 2019
Teas Extension Received
Feb 5, 2019
Noa E-Mailed - Sou Required From Applicant
Dec 11, 2018
Official Gazette Publication Confirmation E-Mailed
Dec 11, 2018
Published For Opposition
Nov 21, 2018
Notification Of Notice Of Publication E-Mailed
Oct 26, 2018
Approved For Pub - Principal Register
Oct 23, 2018
Assigned To Examiner
Jul 7, 2018
New Application Office Supplied Data Entered In Tram
Jul 5, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
